ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 学位論文
  2. 博士論文(医学)
  3. 本文

Assessment of therapeutic effects of combined treatment with cisplatin and anti-mouse programmed death (PD)-1 antibody in a mouse urothelial cancer model

http://hdl.handle.net/10271/0002000469
http://hdl.handle.net/10271/0002000469
0e3d5560-c562-425f-8aab-f0458d23c13d
名前 / ファイル ライセンス アクション
DT_990ronbun.pdf 論文本文 (2.3 MB)
 Download is available from 2026/3/27.
license.icon
Item type 共通アイテムタイプ / Common item types(1)
公開日 2025-07-18
タイトル
タイトル Assessment of therapeutic effects of combined treatment with cisplatin and anti-mouse programmed death (PD)-1 antibody in a mouse urothelial cancer model
言語
言語 eng
キーワード
主題 Urothelial carcinoma
キーワード
主題 cisplatin
キーワード
主題 anti-mouse PD-1 antibody immune checkpoint inhibitor
その他のタイトル
その他のタイトル マウス尿路上皮がんモデルにおけるシスプラチンおよび抗マウスPD-1抗体併用療法の治療効果の評価
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_db06
資源タイプ doctoral thesis
アクセス権
アクセス権 embargoed access
アクセス権URI http://purl.org/coar/access_right/c_f1cf
著者 佐藤, 亮

× 佐藤, 亮

ja 佐藤, 亮
ISNI 浜松医科大学 0000000089376696

ja-Kana サトウ, リョウ

en SATO, Ryo
Hamamatsu University School of Medicine

Search repository
書誌情報 en : ANTICANCER RESEARCH

巻 44, 号 4, p. 1417-1423, 発行日 2024-03-27
出版者
出版者 International Institute of Anticancer Research
権利
権利情報 Copyright 2024 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
抄録
内容記述タイプ Abstract
内容記述 Background/Aim: The therapeutic impact of combination treatment with an immune checkpoint inhibitor (ICI) and chemotherapeutic agent on patients with urothelial cancer (UC) remains controversial. Therefore, the present study investigated differences in the therapeutic effects of combination therapy with cisplatin plus anti-mouse programmed death (PD)-1 antibody according to the dose of cisplatin using the mouse bladder tumor model MBT2. Materials and Methods: The effects of treatment with two different doses cisplatin and/or anti-mouse PD-1 antibody on tumor growth after the subcutaneous injection of MBT2 cells were compared. Infiltrating patterns of lymphocytes into tumors after treatment were assessed using immunohistochemical staining. Results: MBT2 tumor volumes were significantly larger in mice receiving high-dose cisplatin alone than in those receiving low-dose cisplatin alone. Combination treatment with cisplatin plus anti-mouse PD-1 antibody exerted significantly stronger growth inhibitory effects on MBT2 tumors than treatment with either agent alone, irrespective of cisplatin doses; however, no significant differences were observed in MBT2 tumor volumes between mice receiving anti-mouse PD-1 antibody plus high-dose cisplatin and those receiving anti-mouse PD-1 antibody plus low-dose cisplatin. Furthermore, CD8+ to CD3+ and CD8+ to CD11b+ T-lymphocyte ratios in MBT2 tumors were both significantly higher in the low-dose cisplatin alone group than in the high-dose cisplatin alone group, whereas no significant differences were noted in either ratio between the two different combination treatment regimens. Conclusion: When combined with ICI, a lower dose of cisplatin may achieve favorable antitumor effects in UC patients by preventing lymphocyte exhaustion.
学位名
学位名 博士(医学)
学位の区分
内容記述 doctoral
学位の分野
内容記述 医学系研究科
学位授与機関
学位授与機関識別子Scheme kakenhi
学位授与機関識別子 13802
学位授与機関名 浜松医科大学
学位授与機関名 Hamamatsu University School of Medicine
学位授与年月日
学位授与年月日 2024-07-19
学位授与番号
学位授与番号 甲第990号
PISSN
収録物識別子 0250-7005
EISSN
収録物識別子 1791-7530
NII書誌ID (NCID)
収録物識別子 AA10625860
PubMed番号 (PMID)
関連識別子 38537988
出版社DOI
関連識別子 https://doi.org/10.21873/anticanres.16938
学位論文要旨/本文へのリンク
関連識別子 http://hdl.handle.net/10271/0002000242
関連名称 学位論文要旨
出版タイプ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
戻る
0
views
See details
Views

Versions

Ver.1 2025-07-08 05:16:31.361507
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3